Published in
Elsevier, European Journal of Cancer, (75), p. 73-82
DOI: 10.1016/j.ejca.2016.12.032
Links
Tools
Gemcitabine–erlotinib versus gemcitabine–erlotinib–capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group
Journal article published in 2017 by
Antonio Irigoyen,
Javier Gallego,
Carmen Guillén Ponce,
Ruth Vera,
Vega Iranzo 
,
Inmaculada Ales,
Sara Arévalo,
Aleydis Pisa,
Marta Martín,
Antonieta Salud ,
Esther Falcó,
Alberto Sáenz,
José Luis Manzano Mozo,
Gema Pulido,
Joaquina Martínez Galán
and other authors.
,
Inmaculada Ales,
Sara Arévalo,
Aleydis Pisa,
Marta Martín,
Antonieta Salud ,
Esther Falcó,
Alberto Sáenz,
José Luis Manzano Mozo,
Gema Pulido,
Joaquina Martínez Galán
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 